| 000 | 00000nam 2200000za 4500 |
| 001 | 9.524790 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20241115081432 |
|---|
| 007 | ta |
|---|
| 008 | 150406|1994||||xxc||||| f|0| 0 eng d |
|---|
| 020 | |a0-662-22248-2 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 041 | |aeng |
|---|
| 041 | |afre |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH42-2/63-1994 |
|---|
| 110 | 1 |aCanada. |bDrugs Directorate. |
|---|
| 245 | 10|aAcceptable methods |
|---|
| 260 | |aOttawa - Ontario : |bHealth Canada. |c1994. |
|---|
| 490 | 1 |aDrugs Directorate guidelines |
|---|
| 500 | |a"The purpose of this document is to provide guidance concerning the information, including supporting data, that is considered necessary to establish a test method as acceptable to the Health Protection Branch (HPB)."--Introduction. |
|---|
| 520 | 3 |aTells drug manufacturers what information is needed to establish a test method for drug substances, in-process and final bulk products, dosage forms and packaging materials. |
|---|
| 546 | |aBilingual |
|---|
| 563 | |aLoose-leaf |
|---|
| 590 | |a94-40|b1994-10-07 |
|---|
| 690 | 07|aDrugs|2gcpds |
|---|
| 792 | |tMéthodes acceptables |efre|w(CaOODSP)9.524791 |
|---|
| 830 | #0|aDrugs Directorate guidelines.|w(CaOODSP)9.509398 |
|---|